New this year! CEU expands to two cities - Miami and Anaheim - making it more convenient for your schedule. EBR will occur in Miami only.
Updated Clinical Practice Guidelines
Read the Society's updated guidelines: Evaluation and Treatment of Hirsutism in Premenopausal Women on treating unwanted, excess hair growth; and Testosterone Therapy in Men with Hypogonadism on how to diagnose, treat, and monitor hypogonadism.
Read our Scientific Statement on The Science of Obesity Management, from new investigations on the challenges of managing obesity and maintaining weight loss.
- Osteoporosis Drug May Benefit Heart Health
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a study of patients with hip fractures.
- Targeting Cellular Senescence Could Halt Age-Related Bone Loss
Inhibiting cellular senescence could be a novel therapeutic strategy to prevent bone loss and other age-related diseases, according to a mini-review recently published...
- Researchers Compare Health Status, Rates of Cardiometabolic Disease Between Transgender Adults and Cisgender Adults
- ESAP 2018: Diagnosing Tumor-induced Osteomalacia
- Remembering Neena B. Schwartz, PhD: A Lab & Life of Her Making
Clinical Endocrinology Update (CEU) will provide you with the opportunity to learn from and network with faculty at the forefront of endocrine practice and research. Early Registration is now open for:
For endocrinologists determined to go beyond certification and provide the best in patient care, the Endocrine Self-Assessment Program (ESAP™) delivers. ESAP 2018 covers a wide range of topics in endocrinology, diabetes, and metabolism in an online format with a complementary printed book.
We evaluated lipolytic markers, insulin resistance, and hepatic steatosis in response to combined glucocorticoids and obesity in mice. All outcomes were exacerbated in comparison to lean counterparts.
We report a negative association between INSL3 and sclerostin in vivo and in vitro, suggesting new pathways in the emerging role of testis in the regulation of bone metabolism.
We have reviewed the evidence of the gut microbiome as a driving force in the development of obesity and type 2 diabetes mellitus. Considering overlap in potential mechanisms, the role of the gut microbiome in type 1 diabetes mellitus will also be addressed.
Insulin secretion was evaluated in adults who have been exposed in utero to maternal T1D. Only women (not men) exhibited decreased insulin secretion in response to intravenous glucose.